T1	p 21 47	autism spectrum disorder :
T2	p 308 445	autism spectrum disorder ( ASD ) symptoms in children and adolescents with both ASD and attention-deficit/hyperactivity disorder ( ADHD )
T3	p 458 518	total of 97 patients 6-17 years of age , with ASD and ADHD ,
T4	i 6 17	Atomoxetine
T5	i 293 304	atomoxetine
T6	i 554 565	atomoxetine
T7	i 596 614	placebo-controlled
T8	i 662 674	parent-based
T9	i 855 866	atomoxetine
T10	i 1127 1138	atomoxetine
T11	i 1173 1184	atomoxetine
T12	o 62 80	social functioning
T13	o 88 106	beneficial effects
T14	o 110 154	stereotyped behaviors , inappropriate speech
T15	o 157 165	and fear
T16	o 169 175	change
T17	o 662 674	parent-based
T18	o 702 804	, the Aberrant Behavior Checklist ( ABC ) and the Children 's Social Behavior Questionnaire ( CSBQ ) .
T19	o 924 931	effects
T20	o 935 1062	the ABC subscales Hyperactivity , Inappropriate Speech , and Stereotypic Behavior , and on the CSBQ subscale Fear for Changes .
T21	o 1142 1162	social functioning .
T22	o 1211 1256	and stereotyped behaviors and communication .